×

Exelixis CEO: 30,000 men will die of prostate cancer this year

1:39 PM ET Tue, 14 Jan 2014

Michael Morrissey, Exelixis president & CEO, provides insight on clinical research of prostate cancer and its cancer drug Cometriq.